Data / Form D filings / Harpoon Therapeutics, Inc.
Harpoon Therapeutics, Inc.: Form D filings
Harpoon Therapeutics, Inc., a biotechnology company in South San Francisco, CA, filed 4 Form D notices with the SEC between 2017 and 2023. The latest, on October 31, 2023, reports $100.2 million sold of a $100.2 million offering to 18 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 611 GATEWAY BOULEVARD, SUITE 400, South San Francisco, CA, 94080
- Phone
- (650) 443-7400
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $5,000,001 - $25,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1708493
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 31, 2023 | New notice | $100,162,467 | $100,162,467 | 18 | Oct 25, 2023 | sec.gov | |
| Apr 7, 2023 | New notice | $25,000,000 | $25,000,000 | 6 | Mar 23, 2023 | sec.gov | |
| Nov 26, 2018 | New notice | $69,999,993 | $69,999,993 | 17 | Nov 9, 2018 | sec.gov | |
| Jun 6, 2017 | New notice | $45,185,208 | $25,185,208 | $20,000,000 | 7 | May 24, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew Robbins | Director | |
| Julie Eastland | Executive Officer, Director | |
| Luke Walker | Executive Officer | |
| Mark Chin | Director | |
| Scott Myers | Director | |
| Jonathan Drachman | Director | |
| Ronald Hunt | Director | |
| Joseph Bailes | Director | |
| Lauren Silvernail | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Oct 30, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Harpoon Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.